Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective

S Bindu, S Mazumder, U Bandyopadhyay - Biochemical pharmacology, 2020 - Elsevier
Owing to the efficacy in reducing pain and inflammation, non-steroidal anti-inflammatory
drugs (NSAIDs) are amongst the most popularly used medicines confirming their position in …

[HTML][HTML] Evaluation of the association of chronic inflammation and cancer: Insights and implications

M Nigam, AP Mishra, VK Deb, DB Dimri, V Tiwari… - Biomedicine & …, 2023 - Elsevier
Among the most extensively researched processes in the development and treatment of
cancer is inflammatory condition. Although acute inflammation is essential for the wound …

Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial

JR Curtis, K Yamaoka, YH Chen, DL Bhatt… - Annals of The …, 2023 - ard.bmj.com
Objectives To evaluate malignancies and their associations with baseline risk factors and
cardiovascular risk scores with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in …

Cardio-oncology drug interactions: a scientific statement from the American Heart Association

CJ Beavers, JE Rodgers, AJ Bagnola, TM Beckie… - Circulation, 2022 - Am Heart Assoc
In the cardio-oncology population, drug interactions are of particular importance given the
complex pharmacological profile, narrow therapeutic index, and inherent risk of therapies …

New horizons in lung cancer management through ATR/CHK1 pathway modulation

R Thapa, O Afzal, AA Bhat, A Goyal… - Future medicinal …, 2023 - Taylor & Francis
Lung cancer is the leading cause of cancer-related deaths worldwide. Molecular profiling
has contributed to a new classification of lung cancer, driving advancements in research and …

Tofacitinib and risk of malignancy: results from the safety of tofacitinib in routine care patients with rheumatoid arthritis (STAR‐RA) study

F Khosrow‐Khavar, RJ Desai, H Lee… - Arthritis & …, 2022 - Wiley Online Library
Objectives Results of the ORAL Surveillance safety trial have indicated that there is an
increased risk for the development of malignancies with tofacitinib therapy when compared …

Anti-inflammation biomaterial platforms for chronic wound healing

Z Xu, B Liang, J Tian, J Wu - Biomaterials science, 2021 - pubs.rsc.org
Nowadays, there has been an increase in the number of people with chronic wounds, which
has resulted in serious health problems worldwide. The rate-limiting stage of chronic wound …

The role of COX-2 and PGE2 in the regulation of immunomodulation and other functions of mesenchymal stromal cells

A Kulesza, L Paczek, A Burdzinska - Biomedicines, 2023 - mdpi.com
The ability of MSCs to modulate the inflammatory environment is well recognized, but
understanding the molecular mechanisms responsible for these properties is still far from …

Pharmacological control of inflammation in wound healing

SK Shukla, AK Sharma, V Gupta… - Journal of tissue …, 2019 - Elsevier
Wound inflammation is a rapid and highly orchestrated process that significantly impacts the
wound healing cascade. Consequent to injury, a series of events set off that include …

Phytochemical Profiling, Antioxidant and Anti-Inflammatory Activity of Plants Belonging to the Lavandula Genus

N Dobros, KD Zawada, K Paradowska - Molecules, 2022 - mdpi.com
Lavender is a valuable medicinal plant belonging to the Lamiaceae family. Currently 39
species are known, but only Lavandula angustifolia is a pharmacopoeial raw material …